GSK recalls 600,000 Ventolin Inhalers from US
Multinational pharmaceutical company, GlaxoSmithKline (GSK) has announced the recall of over 590,000 Salbutamol (Ventolin) inhalers from the US market, saying there could be issues with the delivery technique.
The recall is for three lots of Ventolin HFA 200D inhalers with lot numbers 6ZP0003, 6ZP9944 and 6ZP9848.
The inhalers, according to reports, have been distributed to hospitals, pharmacies, retailers and wholesalers in the United States.
“There is attainable risk that the affected inhalers could potentially not deliver the stated number of actuations,” according to GSK spokesman Juan Carlos Molina. “We continue to investigate the situation in order to identify the root lead to and implement appropriate corrective and preventative actions.”
The recall is not directed at individuals, but those with inhalers from the recalled lots have been advised to contact the company.
About author
You might also like
Young lab scientists charged on future of Nigerian medical diagnosis
FG not serious with Lassa Fever epidemic, Prof. Dennis Agbonlahor, ex-AMLSN President says ABUJA – The future of medical diagnosis in Nigeria lies in the hands of upcoming medical laboratory
Ebola: Nigeria on red alert
The Management of the Federal Airports Authority of Nigeria (FAAN) has assured Nigerians of adequate surveillance at the nation’s airports following the outbreak of Ebola virus in the Democratic Republic
Revealed! Many Nigerians can’t control their asthma!
A recent survey has revealed that only few Nigerians could be said to be in control of the dreaded condition. According to the Global Strategy for Asthma Management and Prevention (GINA),
0 Comments
No Comments Yet!
You can be first to comment this post!